You searched for "products"
Working with people with hearing loss and dementia
A member of the SENSE-Cog team in the UK, Dr Littlejohn provides an overview of multidisciplinary recommendations for diagnosis, management and care of older adults with hearing loss, vision loss and dementia. She underscores how consideration of hearing status when...Be who you needed when you were younger
Trainee audiologist, deaf England futsal player and deaf advocate Zara Musker discusses finding her own deaf identity: “It’s part of me but not all of me”. Am I an audiologist? A deaf England futsal player? An advocate for deaf individuals?...Annelies Kusters: exploring deaf communities globally
Pioneering deaf scholar, Annelies Kusters, shares insights from her global research journey spanning two decades in deaf communities worldwide. You’ve travelled the world extensively through your work – what’s surprised you most about the different communities that you’ve studied? My...Annelies Kusters: exploring deaf communities globally
Pioneering deaf scholar, Annelies Kusters, shares insights from her global research journey spanning two decades in deaf communities worldwide. You’ve travelled the world extensively through your work – what’s surprised you most about the different communities that you’ve studied? My...BLA Position Statement - Interview with Mark Watson
Author and interviewer: Stefan Linton, ENT Registrar, Manchester Royal Infirmary. We caught up with Mark Watson, President of the British Laryngology Association, to find out his thoughts on the BLA’s position statement on the use of Gardasil vaccination in the...Hearing Care, cognitive decline and dementia: A public health challenge, or an opportunity for healthy ageing?
Brian Lamb, OBE and Sue Archbold PhD, Hon LLD A new document from The Ear Foundation, launched at European Association of Cochlear Implant Users (EURO-CIU) annual general meeting in Poland, reviews the latest evidence on the association between hearing loss,...
Dupilumab prospective RCT for CRSwNP, a multinational trial of 60 patients with a 16-week CT follow-up
This transcontinental work describes a randomised, double blind, placebo controlled parallel group study over a 16-week period, assessing 60 patients with CRSwNP by CT scan scores. All patients had a four-week period of intranasal corticosteroids followed by randomisation to add...
